Roger Dansey
Director/Board Member en INOVIO PHARMACEUTICALS, INC. .
Fortuna: 49 732 $ al 31/03/2024
Perfil
En la actualidad, Roger D. Dansey ocupa el cargo de Director Médico de Seagen Inc. En el pasado, el Dr. Dansey ocupó el cargo de Vicepresidente de Investigación Clínica en Oncología en Gilead Sciences, Inc. y Vicepresidente Senior y Jefe del Área Terapéutica en Merck Research Laboratories Massachusetts LLC. El Dr. Dansey se doctoró en la Universidad de Witwatersrand.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
16/11/2023 | 3 583 ( 0.02% ) | 49 732 $ | 31/03/2024 |
Cargos activos de Roger Dansey
Empresas | Cargo | Inicio |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 13/05/2021 |
KRONOS BIO, INC. | Director/Board Member | 20/04/2023 |
Antiguos cargos conocidos de Roger Dansey.
Empresas | Cargo | Fin |
---|---|---|
SEAGEN INC. | Chief Executive Officer | 09/11/2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01/04/2018 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2014 |
Formación de Roger Dansey.
University of the Witwatersrand | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
- Bolsa de valores
- Insiders
- Roger Dansey